PHASE I FEASIBILITY TRIAL ON A BIWEEKLY SCHEDULE OF CARBOPLATIN AND GEMCITABINE AS FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC NON-SMALL-CELL LUNG CANCER

被引：0
|
作者：
Mancuso, Andrea [1 ]
Migliorino, Maria Rita [1 ]
Martelli, Olga [1 ]
Belli, Raffaele [1 ]
Di Molfetta, Michele [1 ]
De Petris, Luigi [1 ]
Di Salvia, Roberto [1 ]
De Marinis, Filippo [2 ]
机构：
[1] Forlanini Hosp, Dept Resp Dis, Pneumooncol Unit 5, Rome, Italy
[2] Fdn Canc Res FoRO ONLUS, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [21] Extended experience with vinorelbine, gemcitabine and carboplatin as first-line chemotherapy in non-small-cell lung cancer (NSCLC) patients with brain metastases (BM)
    Bernardo, G.
    Palumbo, R.
    Bernardo, A.
    Poggi, G.
    Villani, G.
    Delmonte, A.
    Teragni, C.
    Strada, M. R.
    ANNALS OF ONCOLOGY, 2005, 16 : 160 - 160
  • [22] A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer
    Mori, Kiyoshi
    Kobayashi, Hiroyuki
    Kamiyama, Yukari
    Kano, Yasuhiko
    Kodama, Tetsuro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (01) : 73 - 78
  • [23] A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer
    Kiyoshi Mori
    Hiroyuki Kobayashi
    Yukari Kamiyama
    Yasuhiko Kano
    Tetsuro Kodama
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 73 - 78
  • [24] Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
    F Cappuzzo
    S Novello
    F De Marinis
    V Franciosi
    M Maur
    A Ceribelli
    V Lorusso
    F Barbieri
    L Castaldini
    E Crucitta
    L Marini
    S Bartolini
    G V Scagliotti
    L Crinò
    British Journal of Cancer, 2005, 93 : 29 - 34
  • [25] Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
    Cappuzzo, F
    Novello, S
    De Marinis, F
    Franciosi, V
    Maur, M
    Ceribelli, A
    Lorusso, V
    Barbieri, F
    Castaldini, L
    Crucitta, E
    Marini, L
    Bartolini, S
    Scagliotti, GV
    Crinò, L
    BRITISH JOURNAL OF CANCER, 2005, 93 (01) : 29 - 34
  • [26] Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non-Small-Cell Lung Cancer
    Gronberg, Bjorn H.
    Bremnes, Roy M.
    Flotten, Oystein
    Amundsen, Tore
    Brunsvig, Paal Fr.
    Hjelde, Harald H.
    Kaasa, Stein
    von Plessen, Christian
    Stornes, Froydis
    Tollali, Terje
    Wammer, Finn
    Aasebo, Ulf
    Sundstrom, Stein
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) : 3217 - 3224
  • [27] Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy
    Park, Hyung Soon
    Lim, Sun Min
    Shin, Ho Jung
    Cho, Arthur
    Shin, Jae-Gook
    Lee, Min Goo
    Kim, Hye Ryun
    Kim, Joo Hang
    Cho, Byoung Chul
    PHARMACOGENETICS AND GENOMICS, 2016, 26 (03): : 116 - 125
  • [28] GEMCITABINE-DOCETAXEL VERSUS CISPLATIN-GEMCITABINE AS FIRST-LINE THERAPY IN PATIENTS WITH METASTATIC NON-SMALL-CELL LUNG CANCER
    Al-Gizawy, S. M.
    Mostafa, H. G.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E15 - E15
  • [29] DOCETAXEL AND GEMCITABINE AS FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER: AN EXAMPLE OF TRANSLATIONAL RESEARCH
    Zoli, Wainer
    Cecconetto, Lorenzo
    Dall'Agata, Monia
    Riva, Nada
    Tassinari, Davide
    Calpona, Sebastiano
    Rosti, Giovanni
    Piancastelli, Alessandra
    Frassineti, Giovanni Luca
    ANNALS OF ONCOLOGY, 2004, 15 : 29 - 30
  • [30] Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer:: a phase II trial
    Laack, E
    Mende, T
    Benk, J
    Chemaissani, A
    Scholtze, J
    Lorenz, C
    Niestroy, A
    Dalhoff, K
    Müller, T
    Walter, T
    Dürk, H
    Edler, L
    Hossfeld, DK
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (05) : 583 - 590
12345